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Breast cancer incidence and birth weight are higher among Caucasian than Asian women, and birth size has been positively associated
with breast cancer risk. Pregnancy hormone levels, however, have been generally lower in Caucasian than Asian women. We studied
components of the insulin-like growth factor (IGF) system in cord blood from 92 singleton babies born in Boston, USA, and 110 born
in Shanghai, China, in 1994–1995. Cord blood IGF-1 was significantly higher among Caucasian compared with Chinese babies
(Po10
 6). The opposite was noted for IGF-2 (PB10
 4). IGF-1 was significantly positively associated with birth weight and birth
length in Boston, but not Shanghai. In contrast, stronger positive, though statistically non-significant, associations of IGF-2 with birth
size were only evident in Shanghai. The associations of birth weight and birth length were positive and significant in taller women (for
IGF-1 in Boston PB0.003 and 0.03, respectively; for IGF-2 in Shanghai PB0.05 and B0.04, respectively), among whom maternal
anthropometry does not exercise strong constraints in foetal growth. The documentation of higher cord blood levels of IGF-1, a
principal growth hormone that does not cross the placenta, among Caucasian than in Asian newborns is concordant with breast
cancer incidence in these populations.
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During the past few decades, the possibility has been investigated
that breast cancer can have roots in early life, including the
intrauterine period. By the late 2000s, birth size had become a
predictor of breast cancer risk (Michels and Xue, 2006; Park et al,
2008; dos Santos Silva et al, 2008). We have hypothesised that
high levels of mammotropic hormones during pregnancy favour
the generation of mammary-tissue-specific stem cells in the
offspring and that the pool of these cells is an important
predictor of risk (Trichopoulos et al, 2005). Because such stem
cells are difficult to isolate, haematopoietic stem and progenitor
cells have been used as markers. Concentration of these cells in
cord blood is strongly positively associated with both cord blood
levels of insulin-like growth factor 1 (IGF-1) (Savarese et al, 2007)
and birth weight (Strohsnitter et al, 2008), suggesting that
IGF-1 may be an important factor in the intrauterine origin of
breast cancer.
The incidence of breast cancer (Ferlay et al, 2004), as well as
birth weight (Wen et al, 1995; Lagiou et al, 2003), are higher
among Caucasian women in western countries than in Asian
women in the east. We hypothesised, therefore, that cord blood
levels of IGF-1, which does not cross the placenta (Holmes et al,
1999), are higher among Caucasian than among Asian neonates,
and that cord blood IGF-1 levels are positively associated with
birth size. We evaluated this hypothesis, and also examined the
role of IGF-2, a main component of the IGF system in foetal life,
by studying cord blood samples from babies born to women in
Boston, USA and Shanghai, China.
MATERIALS AND METHODS
Study participants were adult pregnant women and their offspring,
recruited from maternity clinics affiliated with two centres: Beth
Israel Hospital in Boston, USA, and Shanghai Medical University
in China. The study was approved by the Institutional Review
Boards of the two centres, as well as the Institutional Review
Boards of the Harvard School of Public Health and the US
Received 6 March 2009; revised 28 March 2009; accepted 5 April 2009;
published online 5 May 2009
*Correspondence: Dr D Trichopoulos;
E-mail: dtrichop@hsph.harvard.edu
British Journal of Cancer (2009) 100, 1794–1798
& 2009 Cancer Research UK All rights reserved 0007– 0920/09 $32.00
www.bjcancer.com
E
p
i
d
e
m
i
o
l
o
g
yDepartment of the Army. Details on the study have been reported
earlier (Lipworth et al, 1999) and are summarised below.
At each centre, an authorised health professional met all
pregnant women coming for their first routine prenatal visit to
the collaborating maternity clinic, ascertained whether the woman
was eligible to participate, explained to her the objectives of the
study and the requirements for participation, and obtained
informed consent. To be eligible, a pregnant woman had to be
o 40 years of age, have no more than one previous (liveborn or
stillborn) child, be Caucasian in Boston and Chinese in Shanghai,
and be able to understand and speak the local language. Women
were excluded if they had taken any hormonal medication during
the index pregnancy, if they had an earlier diagnosis of diabetes
mellitus or thyroid disease, or if the foetus had a known major
anomaly.
Between March 1994 and October 1995, among 402 women
identified at Beth Israel Hospital in Boston, 304 pregnant women
agreed to participate and met the eligibility criteria. In Shanghai,
among 424 women identified between April 1994 and May 1995,
334 pregnant women agreed to participate and met the eligibility
criteria. In both centres, gestational age was defined as the time
since the first day of the last menstrual period. Baseline
sociodemographic information was recorded and blood was drawn
at gestational weeks 16 and 27. Cord blood was collected and
additional information concerning the delivery and the newborn
was ascertained from medical records and paediatric charts.
Cord blood was collected in sterile tubes without preservatives
and refrigerated at 41C for up to 24h until centrifugation, after
which, serum from each sampling was separated and distributed
into aliquots. In Shanghai, cord blood samples were transported in
a cooler to a laboratory near Shanghai Medical University. Serum
aliquots were stored at  201C for 5–7 days in the laboratory
before being transported to Shanghai Medical University and
stored at  801C. All samples were shipped by air on dry ice to
Boston where they were stored at  801C together with the cord
blood samples from Boston. We were able to collect cord blood
samples of acceptable quality and sufficient quantities for the
determinations of cord blood hormones for 202 uncomplicated
full-term pregnancies (37–42 weeks long without pregnancy
toxaemia), 92 in Boston and 110 in Shanghai.
Hormone determinations were conducted at the ILAT Steroid
RIA Laboratory of the University of Massachusetts Medical School.
IGF-1, IGF-2, and IGFBP-3 were measured by coated-tube
immunoradiometric assay kits (Diagnostic System Laboratories,
Inc., Webster, TX, USA). The laboratory-estimated inter-assay and
intra-assay coefficients of variation were, respectively, 9.0% and
3.3% for IGF-1, 5.9% and 3.4% for IGF-2, and 8.0% and 4.8% for
IGFBP-3. There was no detectable cross reactivity of the IGF-1
assay with IGF-2 according to the manufacturer’s specificity
assessment.
Statistical analyses
Statistical analyses were conducted using the SPSS statistical
package (Statistical Package for Social Sciences v. 16, Chicago, IL,
USA). Multiple regression models were used to compare hormone
levels between Boston and Shanghai controlling for maternal age,
height, duration of gestation and weight gain (all continuously), as
well as for parity and gender of offspring. The association of IGF-1
and IGF-2 with birth weight and birth length were examined by
modelling the data through multiple regression models with,
alternatively, birth weight and length as the outcomes, controlling
also mutually for IGF-1 and IGF-2, as well as for IGFBP-3. Analyses
were conducted separately for each centre, for all women, as well as
for tall and short women, with the cut-off for height set a priori at
163cm (median height in Boston, third quartile in Shanghai) based
on the results of an earlier study (Lagiou et al, 2005). The
hypothesis is that, among shorter women, maternal anthropometry
imposes constraints on birth size (Wen et al, 1995; Lagiou et al,
2003) and could trigger negative feedback mechanisms that could
obscure positive associations of hormones with birth size.
RESULTS
Characteristics of mothers and offspring and cord blood levels of
IGF-1, IGF-2, and IGFBP-3 are shown in Table 1. Caucasian
mothers in Boston were significantly older and taller than Chinese
mothers in Shanghai. In Boston, mothers were in almost equal
proportions primi- and biparae, whereas in Shanghai virtually all
were primiparae. The number of boys and girls was identical in
Boston, but there were substantially more boys than girls in
Shanghai. Birth weight and length were higher in Boston. Table 1
also shows unadjusted mean values and standard deviations of the
three studied components of the IGF axis. Cord blood levels of
IGF-1 were higher in Boston than in Shanghai, whereas the
opposite was evident with respect to IGF-2, while IGFBP-3 levels
were higher in Shanghai.
In Table 2, cord blood levels of IGF-1, IGF-2, and IGFBP-3 are
compared between cities adjusting for maternal age, height, weight
gain, parity, duration of gestation, and gender of offspring. Levels
of IGF-1 were significantly and substantially higher in Boston,
whereas IGF-2 levels were significantly lower. The differences in
IGF-1 and IGF-2 were amplified after adjustment both mutually as
well as for IGFBP-3. As essentially all women in Shanghai were
primiparae, we repeated the analyses for primiparae women only
and the results were essentially unchanged.
Table 3 shows multiple regression-derived partial regression
coefficients of birth weight (upper panel) and birth length (lower
panel) on one standard deviation increments of cord blood levels
of IGF-1 and IGF-2 in Boston and Shanghai, both overall and in
strata defined by maternal height. When all women within each
centre were studied, results were adjusted for maternal age, height,
parity, weight gain, duration of gestation, and gender of offspring.
In the stratified analyses, in which the number of observations was
Table 1 Characteristics
a of mothers and their offspring and cord blood
levels of IGF-1, IGF-2, and IGFBP-3
Boston (n¼92) Shanghai (n¼110)
Age (years) 31.0 (3.0) 25.1 (3.3)
Maternal height (cm) 164.1 (7.2) 160.2 (4.9)
Maternal height
p1.63m 46 (50.0%) 81 (73.6%)
41.63m 46 (50.0%) 29 (26.4%)
Parity
1 48 (52.2%) 109 (99.1%)
2 44 (47.8%) 1 (0.9%)
Duration of gestation (weeks) 40.1 (1.1) 40.0 (1.1)
Maternal weight gain (kg)
b 11.5 (3.9) 8.9 (4.5)
Gender of offspring
Male 46 (50.0%) 64 (58.2%)
Female 46 (50.0%) 46 (41.8%)
Birth weight (g) 3557.7 (490.2) 3492.6 (459.8)
Birth length (cm) 50.6 (2.5) 49.8 (3.1)
IGF-1 (ngml
 1) 98.4 (37.8) 79.0 (48.9)
IGF-2 (ngml
 1) 492.5 (100.3) 587.8 (140.1)
IGFBP-3 (ngml
 1) 2419.1 (1696.8) 3265.3 (2186.4)
IGF¼insulin-like growth factor. Uncomplicated full-term singleton pregnancies in
Boston, USA and Shanghai, China.
aFor continuous variables mean (s.d.); for
categorical variables n (%).
bUntil the 27th week of gestation.
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mally affected within-centre estimates, were not included among
the covariates. In all models, IGF-1 and IGF-2 were adjusted
both mutually and for IGFBP-3. In Boston, with respect to both
birth weight and birth length, there were significant positive
associations with IGF-1; stratified analyses indicated that these
differences were generated exclusively by the offspring of taller
women. In contrast, in Shanghai, IGF-1 was suggestively positively
associated only with birth length and only among taller women
(PB0.11).
The results for IGF-2 were strikingly different. In Boston, no
association was evident with respect to either birth weight or birth
length, neither among women overall nor among taller or shorter
women. In Shanghai, however, cord blood IGF-2 was suggestively
positively associated with birth length (PB0.09), whereas, among
taller women, it was significantly positively associated with both
birth weight and length. The cut-off of 163cm for maternal height
was set a priori. Nevertheless, with respect to birth weight, the
P-value for interaction of maternal height with IGF-1 (both
continuously) was 0.09 for Boston, whereas the P for interaction of
maternal height with IGF-2 was 0.01 in Shanghai.
DISCUSSION
In our study involving pregnancies of 110 Asian women in China
and 92 Caucasian women in USA, we have found that cord blood
IGF-1 was significantly higher in Boston compared with Shanghai
(Po10
 6), whereas the opposite was noted with respect to IGF-2
(PB10
 4) (Table 2). IGF-1 was positively associated with both
birth weight and birth length among newborns in Boston, but not
in Shanghai. With respect to IGF-2 in relation to birth size, there
were suggestive positive associations in Shanghai mostly with
respect to birth length (PB0.09) (Table 3).
In an earlier study (Lagiou et al, 2005), we evaluated the
association of pregnancy estriol in maternal sera with birth weight
after stratification of women by stature. The results supported our
hypothesis that, because among shorter women maternal anthro-
pometry imposes stronger constraints on birth size (Wen et al,
1995; Lagiou et al, 2003), negative feedback mechanisms might
be triggered that masked positive associations of hormones with
birth size. Similarly, in this study, the positive associations of cord
blood IGF with birth weight and length were significant among
taller women for IGF-1 in Boston and for IGF-2 in Shanghai, and
essentially null among women of shorter stature.
Strengths of this investigation are the inclusion of participants
from two populations with contrasting incidence of breast cancer,
the implementation of a uniform protocol, the use of state
of-the-art assays in a qualified laboratory, and the appreciable
study size for a study of this nature. Limitations include lack of
measurements of other IGF-binding proteins and IGF receptors.
Birth size is positively associated with breast cancer risk several
decades later (Michels and Xue, 2006; Park et al, 2008; dos Santos
Silva et al, 2008) and birth weight is higher among Caucasian
newborns in the United States compared with Asian newborns in
China (Wen et al, 1995; Lagiou et al, 2003). The documentation
of higher cord blood levels of IGF-1 among Caucasian compared
with Asian newborns is concordant with the higher incidence of
breast cancer in western compared with eastern Asian populations
(Ferlay et al, 2004) and compatible with the role IGF appears to
play in breast cancer, at least among premenopausal women
(Renehan et al, 2004; Schernhammer et al, 2005). Of note, IGF-1
does not cross the placenta (Holmes et al, 1999) and this was
also supported by our data, in which the correlation coefficients
Table 2 Percent differences
a of cord blood levels of IGF-1, IGF-2, and IGFBP-3 between newborns in Boston, USA (reference) and Shanghai, China
Unadjusted for the other IGF components Adjusted for the other IGF components
Shanghai vs Boston (%) P-value Shanghai vs Boston (%) P-value
IGF-1  39.6 ( 54.3,  20.2) 0.0005  50.9 ( 61.0,  38.1) o10
 6
IGF-2 20.7 (7.7, 35.2) 0.001 23.2 (10.9, 37.0) 0.0001
IGFBP-3 23.0 ( 8.1, 64.7) 0.162 22.5 ( 5.1, 57.9) 0.118
IGF¼insulin-like growth factor.
aAdjusted for maternal age, height and weight gain, parity, duration of gestation, and gender of offspring. Hormone levels were log-transformed,
so that the coefficients express percentage differences between centres.
Table 3 Multiple regression-derived partial regression coefficients b
a (and 95% confidence intervals, CIs) of birth weight (upper panel) and birth length
(lower panel) on one standard deviation increments of cord blood levels of IGF-1, IGF-2, and IGFBP-3 in Boston, USA and Shanghai, China, overall and by
maternal height. Statistically significant P values (o0.05) are indicated in bold fonts.
All women Women p1.63m height Women 41.63m height
Boston (n¼92) Shanghai (n¼110) Boston (n¼46) Shanghai (n¼81) Boston (n¼46) Shanghai (n¼29)
b (CI) P-value b (CI) P-value b (CI) P-value b (CI) P-value b (CI) P-value b (CI) P-value
Birth weight
IGF-1
(per 44.4ngml
 1)
141.7 (11.3, 272.1) 0.03  3.7 ( 133.5, 126.0) 0.96  39.6 ( 252.3, 173.1) 0.71  1.2 ( 139.9, 137.4) 0.99 260.4 (92.6, 428.1) 0.003  33.6 ( 420.6, 353.3) 0.86
IGF 2
(per 132.1ngml
 1)
7.0 ( 131.4, 145.3) 0.92 57.3 ( 51.3, 166.0) 0.30 45.5 ( 137.2, 228.1) 0.62  2.3 ( 124.1, 119.5) 0.97 1.0 ( 196.7, 198.7) 0.99 292.8 (0.59, 584.9) 0.05
Birth length
IGF-1
(per 44.4ngml
 1)
0.85 (0.19, 1.51) 0.01 0.00 ( 0.91, 0.91) 0.99 0.29 ( 0.70, 1.28) 0.56  0.21 ( 1.39, 0.98) 0.73 1.14 (0.09, 2.19) 0.03 0.81 ( 0.19, 1.81) 0.11
IGF-2
(per 132.1ngml
 1)
0.10 ( 0.60, 0.80) 0.77 0.65 ( 0.11, 1.41) 0.09 0.44 ( 0.41, 1.29) 0.30 0.73 ( 0.31, 1.77) 0.17  0.17 ( 1.41, 1.06) 0.78 0.78 (0.02, 1.53) 0.04
IGF¼insulin-like growth factor; CI¼confidence interval.
aAdjusted for maternal age, height and weight gain, parity, duration of gestation, and gender of offspring in models for all
women; adjusted for maternal age and weight gain, and duration of gestation in models by maternal height. In all models, IGF-1 and IGF-2 were adjusted both mutually and for
IGFBP-3.
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finding of higher cord blood levels of IGF-1 among Caucasian
compared with Asian newborns is of particular importance
because, in the same dataset, maternal pregnancy estradiol and
estriol (Lipworth et al, 1999), as well as cord blood estriol,
androstenedione, and testosterone (Troisi et al, 2008) have been
reported to be significantly higher among Chinese than among
Caucasian women. In a small subsample of 52 US and 22 Chinese
newborns from the same dataset, in which IGF-2 was not
measured, there was no significant difference between the two
groups with respect to cord blood IGF-1 and, possibly by chance
owing to the small subsample size, levels of IGF-1 appeared to be
somewhat higher among Chinese newborns (Troisi et al, 2008).
Our results indicating that IGF-1 dominates foetal growth
among Caucasians, whereas IGF-2 plays a similar role among
Asians and that associations are evident among taller mothers are
not directly comparable with previous studies, because mutual
adjustment of IGF-1 and IGF-2 and stratification by maternal
height were not generally undertaken. Nevertheless, cord blood
IGF-1 has shown a consistently positive association with birth
weight in Caucasian (Gluckman et al, 1983; Ashton et al, 1985;
Ostlund et al, 1997; Ong et al, 2000; Christou et al, 2001) and less
consistently in Asian populations (Wang et al, 1991; Yang and
Kim, 2000; Yang and Yu, 2000; Lo et al, 2002; Hung et al, 2008).
Cord blood IGF-2 associations with birth weight are generally
weakly positive or null among both Caucasians (Gluckman et al,
1983; Ashton et al, 1985; Ong et al, 2000) and Asians (Lo et al,
2002; Pathmaperuma et al, 2007; Hung et al, 2008).
Cord blood IGF-1 has been shown to be positively associated
with the size of the stem cell pool (Baik et al, 2005; Savarese et al,
2007), which has also been linked to birth size (Strohsnitter et al,
2008). The stem cell pool has been postulated to be related to
breast cancer risk in later life (Trichopoulos et al, 2005). We found
no reports concerning a possible association of this pool with
IGF-2, which is a growth promoting hormone during gestation
(O’Dell and Day, 1998). In the few analyses based on Asian
populations, there was no relationship between birth size and
breast cancer risk in later life (dos Santos Silva et al, 2008). The
differential actions of IGF-1 and IGF-2 in embryonic life could
be explained by the fact that both IGFs are known to bind to the
signalling IGF-1 receptor, whereas IGF-2 also binds to the non-
signalling IGF-2 receptor (Ong et al, 2000).
Irrespectively of the underlying physiologic mechanisms, the
difference in birth size between Caucasian and Asian newborn can
account for only a small fraction of the differences in breast cancer
incidence. However, the fact that endocrine perinatal influences on
birth size are evident mostly, or exclusively, among newborn of
taller women (Table 3) may explain the sharp contrast in breast
cancer incidence between Caucasian and Asian women—birth size
is positively associated with adult height (Michels et al, 2006) and,
over successive generations, improved nutrition, leading to
increased adult body size, might reduce constraints on foetal
growth and birth size (Wen et al, 1995; Lagiou et al, 2003), which
in turn affects adult height. The cycle tends to repeat itself, notably
over consecutive generations of Asians migrating to the west, who
show a gradual increase of breast cancer incidence (Lagiou et al,
2003; Lagiou and Trichopoulos, 2008). Changes in age at first
pregnancy, parity, and lactation also play a role in the increases of
breast cancer among Asian migrants to western countries
(Haenszel and Kurihara, 1968; Buell, 1973; Ziegler et al, 1993).
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